Breast cancer-related lymphedema and its treatment: how big is the financial impact?
Tessa De VriezeNick GebruersInes NevelsteenWiebren A A TjalmaSarah ThomisAn De GroefLore DamsVincent HaenenNele DevoogdtPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
This study is one of the first standardized high-quality health economic analyses of BRCL treatment in Europe. The present study indicates that the price tag of BCRL treatment in Belgium is high not only for the health insurance but also for the patients Clinical trial registration number The study makes part of a double-blind, multi-center, randomized controlled trial (EFforT-BCRL trial), which is registered in clinicaltrials.gov (NCT02609724). CME reference S58689, EudraCT Number 2015-004822-33.